Title : Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms.

Pub. Date : 2010 Apr 15

PMID : 20130243






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. ruxolitinib Janus kinase 1 Homo sapiens